
    
      This is a Phase 3, randomized, placebo-controlled, double masked, parallel design study in
      healthy subjects performed in the US. It is designed to evaluate the safety and anesthetic
      efficacy of AG-920 Sterile Topical Ophthalmic Solution. In this study, subjects who provide
      informed consent and fulfill all the inclusion criteria and none of the exclusion criteria
      will be randomized in a 1:1 ratio to receive a single dose of AG-920 or identical looking
      placebo into the study eye. Subjects will undergo a conjunctival pinch procedure and the pain
      associated with the pinch rated.
    
  